The best way is to have your skin assessed by a qualified dermatologist. The decision should consider your skin concern, treatment area, product characteristics and desired outcome rather than the treatment name alone.

Not necessarily. A dermatologist should assess your skin, medical history and treatment goals before deciding whether an injectable treatment is appropriate.

Because these are injectable treatments, some discomfort can occur. A topical numbing cream may be used when appropriate, depending on the treatment area and technique.

Results are generally gradual rather than immediate. The timeline varies according to the product, treatment plan and individual response, and a series of sessions may be recommended in some cases.

PN treatments may be considered for skin-quality concerns such as hydration, fine lines, reduced elasticity and tired-looking skin. The appropriate product and technique depend on the treatment area and the patient's goals.

PDRN may be considered as part of a skin-rejuvenation approach when concerns include dullness, uneven texture, early signs of ageing or skin recovery. Suitability depends on the product and individual skin condition.

No. They are closely related but are not necessarily the same. Some scientific and commercial sources use the terms interchangeably, which is one reason patients can find the subject confusing.

Both are DNA-derived materials used in aesthetic dermatology, but their molecular characteristics and formulations can differ. PDRN is generally described as relatively shorter DNA-derived fragments, while PN commonly refers to longer DNA chains. The terminology is not always used consistently, so the specific product matters.